A model to predict short-term death or readmission after intensive care unit discharge☆☆☆★
Abstract
Objective
Early unplanned readmission to the intensive care unit (ICU) carries a poor prognosis, and post-ICU mortality may be related, in part, to premature ICU discharge. Our objectives were to identify independent risk factors for early post-ICU readmission or death and to construct a prediction model.
Design
Retrospective analysis of a prospective database was done.
Setting
Four ICUs of the French Outcomerea network participated.
Patients
Patients were consecutive adults with ICU stay longer than 24 hours who were discharged alive to same-hospital wards without treatment-limitation decisions.
Main results
Of 5014 admitted patients, 3462 met our inclusion criteria. Age was 60.6 ± 17.6 years, and admission Simplified Acute Physiology Score II (SAPS II) was 35.1 ± 15.1. The rate of death or ICU readmission within 7 days after ICU discharge was 3.0%. Independent risk factors for this outcome were age, SAPS II at ICU admission, use of a central venous catheter in the ICU, Sepsis-related Organ Failure Assessment and Systemic Inflammatory Response Syndrome scores before ICU discharge, and discharge at night. The predictive model based on these variables showed good calibration. Compared with SAPS II at admission or Stability and Workload Index for Transfer at discharge, discrimination was better with our model (area under receiver operating characteristics curve, 0.74; 95% confidence interval, 0.68-0.79).
Conclusion
Among patients without treatment-limitation decisions and discharged alive from the ICU, 3.0% died or were readmitted within 7 days. Independent risk factors were indicators of patients' severity and discharge at night. Our prediction model should be evaluated in other ICU populations.
Keywords: discharge, readmission, death, intensive care unit, score(or scoring system)
To access this article, please choose from the options below
☆ Conflicts of interest: The authors have no personal or financial conflicts of interest to declare.
☆☆ Financial support: Outcomerea is supported by nonexclusive educational grants from Pfizer, Aventis Pharma France, Wyeth France, and Ely Lilly and by public grants from the Centre National de la Recherche Scientifique and Institut National de la Santé et la Recherche Medicale. The Outcomerea data warehouse project was also supported by a grant from the Agence Nationale de Valorisation de la Recherche. These grants had no role in the design or conduct of the study; the collection, management, analysis, or interpretation of the data; or the preparation, review, or approval of the manuscript.
★ The results reported in this manuscript were presented, in part, at the 2009 annual meetings of the French Society of Intensive Care Medicine, French Society of Anesthesia and Intensive Care, and European Society of Intensive Care Medicine.
PII: S0883-9441(11)00379-0
doi:10.1016/j.jcrc.2011.08.003
© 2011 Elsevier Inc. All rights reserved.
